Commentary on “Effects of incentive spirometer added to standard rehabilitation in previously hospitalized adults with Post-COVID-19 condition: a randomized controlled trial”

Authors

  • Etika Rana Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation (MMIPR), Maharishi Markandeshwar (Deemed to be University), Mullana, Haryana, India

DOI:

https://doi.org/10.2340/jrm.v58.46243

Keywords:

incentive spirometer, dyspnoea, peak expiratory flow, rehabilitation

Downloads

Download data is not yet available.

References

Kloni M, Heraclides A, Panteli T, Klonis A, Rentzias P, Karagiannis C. Effects of incentive spirometer added to standard rehabilitation in previously hospitalized adults with post-COVID-19 condition: a randomized controlled trial. J Rehabil Med 2026; 58: jrm44926. DOI: https://doi.org/10.2340/jrm.v58.44926

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57: 289–300. DOI: https://doi.org/10.1111/j.2517-6161.1995.tb02031.x

Ioannidis JPA. Why most discovered true associations are inflated. Epidemiology 2008; 19: 640–648. DOI: https://doi.org/10.1097/EDE.0b013e31818131e7

Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323: 1123–1124. DOI: https://doi.org/10.1136/bmj.323.7321.1123

Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332. DOI: https://doi.org/10.1136/bmj.c332

Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated international task force. Eur Respir J 2020; 56: 2002197. DOI: https://doi.org/10.1183/13993003.02197-2020

Hyatt RE, Scanlon PD, Nakamura M. Interpretation of pulmonary function tests: a practical guide. 4th ed. Philadelphia, PA: Wolters Kluwer; 2014.

Sullivan GM, Feinn R. Using effect size – or why the P value is not enough. J Grad Med Educ 2012; 4: 279–282. DOI: https://doi.org/10.4300/JGME-D-12-00156.1

Soril LJJ, Damant RW, Lam GY, Smith MP, Weatherald J, Bourbeau J, et al. The effectiveness of pulmonary rehabilitation for post-COVID symptoms: a rapid review of the literature. Respir Med 2022; 195: 106782. DOI: https://doi.org/10.1016/j.rmed.2022.106782

Egbewale BE, Lewis M, Sim J. Bias, precision and statistical power in analysis of covariance compared with change score methods in randomized controlled trials: a simulation study. BMC Med Res Methodol 2014; 14: 49. DOI: https://doi.org/10.1186/1471-2288-14-49

Walker PP, Key AL. How to perform peak flow and spirometry tests. BMJ 2016; 353: h6159. DOI: https://doi.org/10.1136/sbmj.h6159

Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester CL, et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64.

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–586. DOI: https://doi.org/10.1136/thx.54.7.581

Downloads

Published

2026-07-09

How to Cite

Rana, E. (2026). Commentary on “Effects of incentive spirometer added to standard rehabilitation in previously hospitalized adults with Post-COVID-19 condition: a randomized controlled trial”. Journal of Rehabilitation Medicine, 58, jrm46243. https://doi.org/10.2340/jrm.v58.46243

Issue

Section

Commentary

Categories